According to our latest study on “Ablation Device Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis” the market was valued at US$ 8,325.32 million in 2022 and is projected to reach US$ 16,020.33 million by 2030; it is estimated to register a CAGR of 8.5 % from 2022 to 2030. The report highlights the key factors driving the ablation device market growth and prominent players with their developments in the market.
Ablation refers to the surgical removal of an organ, structure, or part. Ablation devices use heat (usually generated by radio frequency, RF, energy, or a laser) or extreme cold to cause minor burns.
Get Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00003095/
Abbott Laboratories, AngioDynamics, Inc., AtriCure, Inc., Biotronik, Boston Scientific Corporation, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, and Smith & Nephew PLC are among the leading companies operating in the global ablation device market.
Companies operating in the ablation device market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the ablation device market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall ablation device market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.
· In May 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved the company’s TactiFlex Ablation Catheter, Sensor Enabled, the world’s first ablation catheter with a flexible tip and contact force technology.
· In February 2023, Hologic Inc. announced the approval of the NovaSure V5 global endometrial ablation (GEA) device in Canada and Europe. The innovative new version incorporates enhanced features designed to treat a wide range of cervical and uterine anatomies. It builds on a world-class track record for NovaSure, including 3 million patients who have benefited from the device.
· In November 2021, Medtronic India launched the Arctic Front Cardiac Cryoablation Catheter System for the treatment of Atrial Fibrillation (AF) in the country. Cryoballoon catheter ablation is a minimally invasive procedure and one of the therapeutic modalities to manage AF.
· In January 2021, Medtronic plc announced that it received U.S. Food and Drug Administration (FDA) approval for the DiamondTemp Ablation (DTA) system, which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) who have been unresponsive to drug therapy. The DiamondTemp system was the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.
· In December 2020, Acutus Medical launched the AcQBlate Force Sensing Ablation System in Europe after securing CE Mark for the company’s AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module (Qubic Force). The AcQBlate Force Sensing Ablation System, which incorporates the first and only commercially available gold-tipped, irrigated, force-sensing radiofrequency ablation catheter on the market (AcQBlate Force), also integrates two state-of-the-art components made available through Acutus Medical’s international alliance with BIOTRONIK: the Qubic Radiofrequency Generator (Qubic RF) and the Qiona Irrigation Pump.
· In November 2020, Abbott announced the launch of the IonicRF Generator – a device cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain. The device is currently approved in the United States and Europe.
About Us:
The Insight Partners is a market research solution and consultation company. Specializing in syndicate market research, our team helps clients in their hunt for revenue pockets in several industries. A team of 250+ research experts is dedicated to offering the most relevant, data-driven, and trustworthy market insights and consultation.
Contact Us:
If you have any queries about this report or if you would like further information, please contact u
The Insight Partners
Phone: +1-646-491-9876
E-mail: [email protected]
